mechlorethamine has been researched along with Lymphoma, Non-Hodgkin in 176 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the long-term outcome of patients presenting with synchronous lymphoma and severe liver dysfunction and to describe the outcome of patients treated with initial mechlorethamine-based therapy used as a bridge to more conventional chemotherapy." | 3.72 | Therapeutic options in patients with lymphoma and severe liver dysfunction. ( Ansell, SM; Colgan, JP; Fonseca, R; Ghobrial, IM; Habermann, TM; Inwards, DJ; Markovic, SN; Micallef, IN; Pereira, DL; Porrata, LF; White, WL; Witzig, TE; Wolf, RC, 2004) |
| "Fourteen had Hodgkin's and four non-Hodgkin's lymphoma." | 2.68 | Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. ( Avivi, I; Ben-Shahar, M; Blumenfeld, Z; Epelbaum, R; Haim, N; Linn, S, 1996) |
| "The response rate and survival in diffuse histiocytic lymphoma have improved since the first study." | 2.64 | Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group. ( Coltman, CA; Jones, SE; Luce, JK; McKelvey, EM; Moon, TE, 1977) |
| "Malignant lymphoma is classified into the following five major categories: aggressive lymphoma, indolent B-lymphoma, Hodgkin's disease, T-lymphoblastic lymphoma and adult T-cell leukemia-lymphoma (ATL)." | 2.39 | [Recent progress in the chemotherapy of malignant lymphoma]. ( Tobinai, K, 1995) |
| "Chemotherapy of malignant lymphomas has accomplished a significant progress during the two decades." | 2.38 | [Current status of chemotherapy in the treatment of malignant lymphomas]. ( Hayashi, K; Kimura, I; Mizuta, J; Murashima, M; Ohnoshi, T; Tada, A; Tagawa, S; Ueno, K, 1989) |
| "Seventy-five Hodgkin lymphoma and non-Hodgkin lymphoma patients and a control group of 257 fertile men." | 1.40 | Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network. ( Auger, J; Berthaut, I; Brugnon, F; Bujan, L; Daudin, M; Hennebicq, S; Moinard, N; Rives, N; Saias, J; Szerman, E; Walschaerts, M, 2014) |
| "Of the 13 cases, 5 were Hodgkin's disease (HD), and 8 were non-Hodgkin's lymphoma (NHL)." | 1.33 | [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma]. ( Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ, 2006) |
| "We followed-up 33 patients with non-Hodgkin's lymphoma or with Hodgkin's disease during the years 1987-1997 who were referred for semen cryopreservation." | 1.31 | Follow-up of sperm concentration and motility in patients with lymphoma. ( Botchan, A; Hauser, R; Paz, G; Tal, R; Yavetz, H; Yogev, L, 2000) |
| "Patients treated for Hodgkin's disease and non-Hodgkin lymphomas were followed for 5 years after start of therapy." | 1.30 | Five-year follow-up of saliva in patients treated for lymphomas. ( Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L, 1997) |
| "The occurrence of HIV associated non-Hodgkin's lymphoma (NHL) is a well recognized event." | 1.29 | Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient. ( Brody, J; Goh, JC; Kaplan, MH; Koduru, P; Lichtman, SM; Susin, M, 1993) |
| "More than 50% of patients with non Hodgkin's lymphomas (NHL) are long-term survivors." | 1.29 | [Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993]. ( Auger, J; Bendahmane, B; Decaudin, D; Koscielny, S; Munck, JN; Naccache, P, 1996) |
| "The frequency of chromosome aberrations in the peripheral blood of patients successfully treated for Hodgkin's disease (HD) and non-Hodgkin's lymphoma is compared with that seen in age-matched haematologically normal subjects." | 1.28 | Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma. ( Clark, RE; Jacobs, A; Jones, BM; White, AD, 1992) |
| "Patients with diffuse histiocytic lymphoma who achieved a histologically proven complete remission after 6 months of treatment without maintenance have remained disease-free whereas those with nodular poorly differentiated lymphocytic and diffuse well-differentiated lymphocytic lymphomas have demonstrated a pattern of continuous late recurrence." | 1.25 | Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy. ( Canellos, GP; Chabner, BA; DeVita, VT; Schein, PS; Young, RC, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 126 (71.59) | 18.7374 |
| 1990's | 33 (18.75) | 18.2507 |
| 2000's | 12 (6.82) | 29.6817 |
| 2010's | 3 (1.70) | 24.3611 |
| 2020's | 2 (1.14) | 2.80 |
| Authors | Studies |
|---|---|
| Zimmerman, K | 1 |
| Walsh, KA | 1 |
| Ferrari, JT | 1 |
| Keuler, NS | 1 |
| Atherton, MJ | 1 |
| Lenz, JA | 1 |
| Wehkamp, U | 1 |
| Jost, M | 1 |
| Gosmann, J | 1 |
| Grote, U | 1 |
| Bernard, M | 1 |
| Stadler, R | 1 |
| Bujan, L | 1 |
| Walschaerts, M | 1 |
| Brugnon, F | 1 |
| Daudin, M | 1 |
| Berthaut, I | 1 |
| Auger, J | 2 |
| Saias, J | 1 |
| Szerman, E | 1 |
| Moinard, N | 1 |
| Rives, N | 1 |
| Hennebicq, S | 1 |
| HUNTER, OB | 1 |
| EICHENLAUB, FJ | 1 |
| OLIVO, MA | 1 |
| WINTROBE, MM | 4 |
| HUGULEY, CM | 2 |
| SHERRY, M | 1 |
| Cronin, PA | 1 |
| Myers, E | 1 |
| Redmond, HP | 1 |
| O'Reilly, S | 1 |
| Kirwan, WO | 1 |
| GOODMAN, LS | 2 |
| Fenn, JE | 1 |
| Udelsman, R | 1 |
| NARDI, FL | 1 |
| KLIMA, R | 1 |
| HORNISCHER, R | 1 |
| SIEVERS, K | 1 |
| HARWERTH, HG | 1 |
| MEYER, OO | 1 |
| KAWAMURA, H | 1 |
| ITANO, T | 1 |
| SKINNER, EF | 1 |
| ISBELL, H | 1 |
| CARR, D | 1 |
| INTROZZI, P | 1 |
| MARINONE, G | 1 |
| BEATTIE, JW | 1 |
| HOWELLS, LH | 1 |
| HOCHMAN, A | 2 |
| ICKOWICZ, M | 1 |
| SOROKIN, NM | 1 |
| EBERHARD, R | 1 |
| GAJARDO, M | 1 |
| RATH, CE | 1 |
| THOMSON, TJ | 1 |
| HAASE, S | 1 |
| RATZKOWSKI, A | 1 |
| SPAIN, DM | 1 |
| DI PIETRO, S | 2 |
| BERNARD, J | 3 |
| MATHE, G | 2 |
| WEIL, M | 3 |
| LOVISETTO, P | 1 |
| CASTELLANO, M | 1 |
| LAMBERS, K | 1 |
| JACKSON, K | 1 |
| McGREW, E | 1 |
| COLE, WH | 1 |
| WINKLER, JW | 1 |
| ROOSA, RA | 1 |
| DELAMATER, ED | 1 |
| KRASOVSKII, II | 1 |
| IAKOVLEV, AM | 1 |
| BELLELLI, L | 1 |
| SPEAR, PW | 1 |
| PATNO, ME | 1 |
| WATSON, JI | 1 |
| WILKINSON, RD | 1 |
| CRAIG, GE | 1 |
| MOLANDER, DW | 1 |
| ZEZZANETO, L | 1 |
| SOERENSEN, B | 1 |
| SALIBA, AM | 1 |
| GRECCHI, R | 1 |
| SMITH, JC | 1 |
| CREPALDI, G | 1 |
| PARPAJOLA, A | 1 |
| MURPHY, WT | 1 |
| BILGE, N | 1 |
| MCALISTER, WH | 1 |
| MARGULIS, AR | 1 |
| BURNINGHAM, RA | 1 |
| RESTREPO, A | 1 |
| PUGH, RP | 1 |
| BROWN, EB | 1 |
| SCHLOSSMAN, SF | 1 |
| KHURI, PD | 1 |
| LESSNER, HE | 1 |
| HARRINGTON, WJ | 1 |
| DIAMANDOPOULOS, GT | 1 |
| SMITH, EB | 1 |
| KRESS, MB | 1 |
| HIRSCHFELD, JH | 1 |
| TANIDA, T | 1 |
| FUJIMORI, M | 1 |
| SAKAUCHI, G | 1 |
| IZUO, M | 1 |
| ABE, C | 1 |
| MORITA, S | 1 |
| NASHIMOTO, T | 1 |
| ISHIKAWA, S | 1 |
| SADMITSU, H | 1 |
| KAWAI, T | 1 |
| PAPAC, RJ | 1 |
| WOOD, DA | 2 |
| IRIARTE, P | 1 |
| JAGASIA, H | 1 |
| THURMAN, WG | 1 |
| KARNOFSKY, DA | 2 |
| HUTCHISON, JL | 1 |
| CLARKSON, B | 1 |
| VANDERVELDE, SL | 1 |
| HOVORKA, JJ | 1 |
| BROCKHOUSE, JP | 1 |
| ROBINSON, BE | 1 |
| HOYNE, RM | 1 |
| HALNAN, KE | 1 |
| MORROW, LB | 1 |
| ANDERSON, RE | 1 |
| CLIFFORD, P | 1 |
| BHARDWAJ, BV | 1 |
| WHITTAKER, LR | 1 |
| MELANDRI, F | 1 |
| PATRONCINI, F | 1 |
| PRADHAN, SN | 1 |
| WEST, WL | 1 |
| RABENKO, J | 2 |
| CORREA URQUIZA, LM | 1 |
| Ogawa, M | 1 |
| Mandigers, CM | 1 |
| Verdonck, LF | 1 |
| Meijerink, JP | 1 |
| Dekker, AW | 1 |
| Schattenberg, AV | 1 |
| Raemaekers, JM | 2 |
| Hehn, ST | 1 |
| Miller, TP | 2 |
| MARTINEZ PENUELA, JM | 1 |
| MASOUREDIS, SP | 1 |
| LOW-BEER, BV | 1 |
| BIERMAN, HR | 1 |
| CHERNEY, LS | 1 |
| SHIMKIN, MB | 1 |
| BADER, DN | 1 |
| LEVI, M | 1 |
| MENE, G | 1 |
| FERRI, A | 1 |
| JOYEUX, R | 1 |
| COURTY, A | 1 |
| BERTRAND, L | 1 |
| de LORENZO, J | 1 |
| JANNINI, P | 1 |
| BARENGHI, G | 1 |
| ABOU SINNA, I | 1 |
| BERTLICH, W | 1 |
| HEITE, HJ | 1 |
| GARCIA PEREZ, A | 1 |
| QUINONES CARAVIA, PA | 1 |
| KIELER, J | 1 |
| Ghobrial, IM | 1 |
| Wolf, RC | 1 |
| Pereira, DL | 1 |
| Fonseca, R | 1 |
| White, WL | 1 |
| Colgan, JP | 1 |
| Habermann, TM | 1 |
| Inwards, DJ | 1 |
| Markovic, SN | 1 |
| Ansell, SM | 1 |
| Micallef, IN | 1 |
| Porrata, LF | 1 |
| Witzig, TE | 1 |
| SAITA, G | 1 |
| SWEITZER, SE | 1 |
| CUMMING, HA | 1 |
| McAFEE, GD | 1 |
| CABY, F | 1 |
| TSEVRENIS, H | 1 |
| Wessels, G | 1 |
| Bernard Hesseling, P | 1 |
| Moser, EC | 1 |
| Noordijk, EM | 3 |
| Carde, P | 2 |
| Tirelli, U | 3 |
| Baars, JW | 1 |
| Thomas, J | 3 |
| Bron, D | 2 |
| Meerwaldt, JH | 3 |
| van Glabbeke, M | 2 |
| Kluin-Nelemans, HC | 1 |
| Zhen, ZJ | 1 |
| Sun, XF | 1 |
| Xia, Y | 1 |
| Wang, ZH | 1 |
| Ling, JY | 1 |
| Bachmeyer, C | 1 |
| Orlandini, V | 1 |
| Aractingi, S | 1 |
| BEN-ASHER, S | 1 |
| MEYER, AH | 1 |
| OVERMILLER, WC | 1 |
| Shohat, B | 1 |
| Gitter, S | 1 |
| Lavie, D | 1 |
| Klastersky, J | 1 |
| Giustolisi, R | 1 |
| Guglielmo, P | 1 |
| Di Raimondo, F | 1 |
| Milone, G | 1 |
| Cacciola, E | 1 |
| Jacquillat, C | 1 |
| Khayat, D | 1 |
| Desprez-Curely, JP | 1 |
| Brocheriou, C | 1 |
| Auclerc, G | 1 |
| Chamseddine, N | 1 |
| Dameshek, W | 2 |
| Goodman, MJ | 1 |
| Gilman, A | 1 |
| McLennan, MT | 1 |
| Coyne, J | 1 |
| Dervan, P | 1 |
| Portlock, CS | 1 |
| Somers, R | 3 |
| Keuning, JJ | 1 |
| Delmer, A | 1 |
| de Bock, R | 1 |
| De Wolf-Peeters, C | 2 |
| Keunig, JJ | 1 |
| Sertoli, MR | 1 |
| Santini, G | 2 |
| Chisesi, T | 2 |
| Congiu, AM | 1 |
| Rubagotti, A | 1 |
| Contu, A | 2 |
| Salvagno, L | 2 |
| Coser, P | 2 |
| Porcellini, A | 2 |
| Vespignani, M | 1 |
| Longo, DL | 4 |
| Duffey, PL | 2 |
| Jaffe, ES | 3 |
| Raffeld, M | 1 |
| Hubbard, SM | 3 |
| Fisher, RI | 6 |
| Wittes, RE | 1 |
| DeVita, VT | 8 |
| Young, RC | 5 |
| Tobinai, K | 2 |
| Teodorovic, I | 2 |
| Pittaluga, S | 2 |
| Kluin-Nelemans, JC | 1 |
| Hagenbeek, A | 2 |
| Bijnens, L | 2 |
| Peeters, CD | 1 |
| Lichtman, SM | 1 |
| Brody, J | 1 |
| Kaplan, MH | 1 |
| Susin, M | 1 |
| Koduru, P | 1 |
| Goh, JC | 1 |
| Anderson, JR | 1 |
| Vose, J | 1 |
| Kessinger, A | 1 |
| Jurcic, JG | 1 |
| Koll, B | 1 |
| Brown, AE | 1 |
| Crown, JP | 1 |
| Yahalom, J | 1 |
| Gulati, SC | 1 |
| Baxter, JD | 1 |
| DiNubile, MJ | 1 |
| Nagourney, RA | 1 |
| Evans, SS | 1 |
| Messenger, JC | 1 |
| Su, YZ | 1 |
| Weisenthal, LM | 1 |
| Bokemeyer, C | 1 |
| Schmoll, HJ | 1 |
| van Rhee, J | 1 |
| Kuczyk, M | 1 |
| Schuppert, F | 1 |
| Poliwoda, H | 1 |
| Kaźmierczak, M | 1 |
| Komarnicki, M | 1 |
| Kroll, R | 1 |
| Haim, N | 3 |
| Leviov, M | 1 |
| Ben-Arieh, Y | 1 |
| Epelbaum, R | 2 |
| Freidin, N | 1 |
| Reshef, R | 1 |
| Ben-Shahar, M | 3 |
| Naccache, P | 1 |
| Decaudin, D | 1 |
| Koscielny, S | 1 |
| Bendahmane, B | 1 |
| Munck, JN | 1 |
| Gaynor, ER | 2 |
| Blumenfeld, Z | 2 |
| Avivi, I | 1 |
| Linn, S | 1 |
| Meurman, JH | 2 |
| Laine, P | 2 |
| Keinànen, S | 1 |
| Pyrhönen, S | 2 |
| Teerenhovi, L | 2 |
| Lindqvist, C | 2 |
| Kamieńska, E | 1 |
| Corti, C | 1 |
| Theodore, C | 1 |
| Bayle, C | 1 |
| Rougier, P | 1 |
| Nasr, F | 1 |
| Cosset, JM | 1 |
| Girinsky, T | 1 |
| Hayat, M | 1 |
| Ribrag, V | 1 |
| Ritter, M | 1 |
| Shen-Orr, Z | 1 |
| Shariki, K | 1 |
| Bairey, O | 1 |
| Gabbay, U | 1 |
| Blickstein, D | 1 |
| Stark, P | 1 |
| Prokocimer, M | 1 |
| Epstein, O | 1 |
| Shaklai, M | 1 |
| Lahav, J | 1 |
| Kuraishi, Y | 1 |
| Usui, N | 1 |
| Dobashi, N | 1 |
| Poloni, A | 1 |
| Leoni, P | 1 |
| Curzi, L | 1 |
| Cantori, I | 1 |
| Mancini, S | 1 |
| Montanari, M | 1 |
| Masia, MC | 1 |
| Olivieri, A | 1 |
| Dubey, SP | 1 |
| Sengupta, SK | 1 |
| Kaleh, LK | 1 |
| Morewaya, JT | 1 |
| Dana, BW | 1 |
| LeBlanc, M | 1 |
| Kjeldsberg, C | 1 |
| Forman, JD | 1 |
| Unger, JM | 1 |
| Balcerzak, SP | 1 |
| Roy, V | 1 |
| Miller, T | 1 |
| Tal, R | 1 |
| Botchan, A | 1 |
| Hauser, R | 1 |
| Yogev, L | 1 |
| Paz, G | 1 |
| Yavetz, H | 1 |
| Cabanillas, F | 1 |
| Avilés, A | 2 |
| Neri, N | 1 |
| Johnson, LP | 1 |
| Rivkin, SE | 1 |
| Weber, EL | 1 |
| Bonadonna, G | 1 |
| De Lena, M | 1 |
| Lattuada, A | 1 |
| Milani, F | 1 |
| Monfardini, S | 1 |
| Beretta, G | 1 |
| Anderson, T | 1 |
| Bender, RA | 1 |
| Chabner, BA | 2 |
| Berard, CW | 1 |
| Norton, L | 1 |
| Coltman, CA | 1 |
| Luce, JK | 2 |
| McKelvey, EM | 1 |
| Jones, SE | 1 |
| Moon, TE | 1 |
| Goldberg, J | 1 |
| Davey, FR | 1 |
| Gottlieb, AJ | 1 |
| Klein, HO | 1 |
| Bar-Meir, S | 1 |
| Pinkhas, J | 1 |
| Golan, A | 1 |
| Vries, A | 1 |
| Kaufman, JH | 1 |
| Ezdinli, E | 1 |
| Aungst, CW | 1 |
| Stutzman, L | 2 |
| Schein, PS | 1 |
| Canellos, GP | 2 |
| Tenovuo, J | 1 |
| Murtomaa, H | 1 |
| Dodwell, DJ | 1 |
| de Campos, ES | 1 |
| Radford, JA | 1 |
| White, AD | 1 |
| Jones, BM | 1 |
| Clark, RE | 1 |
| Jacobs, A | 1 |
| Wesley, MN | 1 |
| Ihde, DC | 2 |
| Gilliom, M | 1 |
| Cossman, J | 1 |
| Díaz-Maqueo, JC | 1 |
| Talavera, A | 1 |
| Guzmán, R | 1 |
| García, EL | 1 |
| Capnist, G | 1 |
| Rizzoli, V | 1 |
| Sertoli, M | 1 |
| Rancan, L | 1 |
| Gisselbrecht, C | 2 |
| Lepage, E | 2 |
| Sebban, C | 1 |
| Coiffier, B | 1 |
| Cunningham, D | 1 |
| Hepplestone, A | 1 |
| Gilchrist, NL | 1 |
| Dagg, JH | 1 |
| Evans, IL | 1 |
| Soukop, M | 1 |
| Sagher, D | 1 |
| Karrison, T | 1 |
| Schwartz, JL | 1 |
| Larson, R | 1 |
| Meier, P | 1 |
| Strauss, B | 1 |
| Brice, P | 1 |
| Trédaniel, J | 1 |
| Gerota, I | 1 |
| Glatstein, E | 1 |
| Zagonel, V | 1 |
| Volpe, R | 1 |
| Trovò, MG | 1 |
| Carbone, A | 1 |
| Ohnoshi, T | 1 |
| Hayashi, K | 1 |
| Ueno, K | 1 |
| Tada, A | 1 |
| Murashima, M | 1 |
| Mizuta, J | 1 |
| Tagawa, S | 1 |
| Kimura, I | 1 |
| Brown, T | 1 |
| Dawson, AA | 1 |
| Bennett, B | 1 |
| Moore, NR | 1 |
| España, P | 1 |
| Bonilla, F | 1 |
| Yebra, M | 1 |
| Diego, J | 1 |
| Alvarez de Mon, M | 1 |
| Marazuela, M | 1 |
| Durántez, A | 1 |
| Anderson, CB | 1 |
| Philpott, GW | 1 |
| Ferguson, TB | 1 |
| Knock, FE | 1 |
| Galt, RM | 1 |
| Oester, YT | 1 |
| Sylvester, R | 1 |
| Keipert, JA | 1 |
| Roughon, C | 1 |
| Levacher, JP | 1 |
| Vaugier, G | 1 |
| Van Thiel, DH | 1 |
| Sherins, RJ | 2 |
| Myers, GH | 1 |
| De Vita, VT | 1 |
| Reilly, CJ | 1 |
| Han, T | 1 |
| Slack, NH | 1 |
| Webster, J | 1 |
| Le Bourgeois, JP | 1 |
| Delobel, J | 1 |
| Wiltshaw, E | 1 |
| Millett, Y | 1 |
| Solomon, J | 1 |
| Jacobs, EM | 2 |
| Bateman, JR | 1 |
| Lukes, RJ | 1 |
| Weiner, JM | 1 |
| Donohue, DM | 1 |
| Carbone, PP | 1 |
| Rubin, P | 2 |
| Arseneau, JC | 1 |
| Frei, E | 1 |
| Peters, FC | 1 |
| Zippin, C | 1 |
| Lowenbraun, S | 1 |
| Serpick, AA | 1 |
| Gamble, JF | 1 |
| Fuller, LM | 1 |
| Butler, JJ | 1 |
| Shullenberger, CC | 1 |
| Muller, SA | 1 |
| Schulze, TW | 1 |
| Lewinski, U | 1 |
| Garrett, MJ | 1 |
| Glazebrook, GA | 1 |
| el-Akkad, SM | 1 |
| Shakir, MA | 1 |
| DeConti, RC | 1 |
| Kaplan, SR | 1 |
| Calabresi, P | 1 |
| Bruneau, R | 1 |
| Lenhard, RE | 1 |
| Owens, AH | 1 |
| Perez, CA | 1 |
| Olson, J | 1 |
| Lewis, FB | 1 |
| Schwartz, RS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell Lymphoma[NCT00005780] | Phase 2 | 26 participants (Actual) | Interventional | 2000-06-01 | Completed | ||
| Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis Or Treatment Regimen: A Study By The National Physicians Cooperative of the Oncofertility Consortium At Northwestern University[NCT00902720] | Phase 4 | 25 participants (Anticipated) | Interventional | 2009-05-31 | Recruiting | ||
| Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being[NCT02749474] | 400 participants (Anticipated) | Observational [Patient Registry] | 2003-07-31 | Recruiting | |||
| A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodg[NCT00479167] | Phase 2 | 1 participants (Actual) | Interventional | 2007-05-31 | Terminated (stopped due to Lack of accrual and interest in study) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Here is the number of participants with serious and/or non-serious adverse events assessed by the Common Toxicity Criteria (CTC v2.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life-threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT00005780)
Timeframe: Up to 30 days after last intervention, up to 12.5 months or 1.04 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab | 26 |
PFS is time from on study date until disease relapse or progression, death, or date of last follow-up. Progression was measured by the International Workshop to Standardize Response Criteria for non-Hodgkin's Lymphoma and is defined as ≥50% increase from nadir in the sum of the products of the greatest diameters (SPD) of any previously involved node or the appearance of any new lesion. (NCT00005780)
Timeframe: From participants on study date until date of disease relapse or progression, death, or date of last follow-up, assessed up to 245.8 months
| Intervention | Months (Median) |
|---|---|
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab | 23.5 |
OS was determined by the Kaplan-Meier method and is defined as the time from treatment start date until date of death or last follow-up. (NCT00005780)
Timeframe: Time from treatment start date until date of death or date last follow-up, up to 250 months
| Intervention | Months (Median) |
|---|---|
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab | 89.7 |
Participants with an immune response to idiotype vaccine measured by enzyme-linked immunosorbent assay (ELISA) to detect antibody binding to tumor cells. Positive response was defined as at least a fourfold increase in antibody titer. (NCT00005780)
Timeframe: Weeks 12 to 32
| Intervention | percentage of participants (Number) |
|---|---|
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab | 30 |
Participants with an immune response against carrier molecule KLH measured by enzyme-linked immunosorbent assay (ELISA) to detect antibody binding to tumor cells. Positive response was defined as at least a fourfold increase in antibody titer. (NCT00005780)
Timeframe: After vaccinations administered at 0, 1, 2, 3 and 5 months
| Intervention | percentage of participants (Number) |
|---|---|
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab | 74 |
PFS is defined as the time from start of treatment until disease relapse or progression, death, or last follow-up. Progression was measured by the International Workshop to Standardize Response Criteria for non-Hodgkin's Lymphoma and is defined as ≥50% increase from nadir in the sum of the products of the greatest diameters (SPD) of any previously involved node or the appearance of any new lesion (NCT00005780)
Timeframe: Time from treatment start date until date of disease relapse or progression, death, or date last follow-up, an average of 25 months
| Intervention | Months (Median) |
|---|---|
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab | 25.0 |
Recovery of CD4+ was measured by flow cytometry. Blood samples were collected via apheresis and analyzed by multicolor flow cytometry in peripheral blood mononuclear cells (PBMCs) for cluster of differentiation 4 (CD4). Time to recovery of CD4 T lymphocytes was defined as the time required for CD4 T lymphocytes to increase above the lower limit of normal of the normal laboratory value range of 359 cells/mcL (NCT00005780)
Timeframe: After chemotherapy before vaccination, up to 6 months
| Intervention | Months (Median) |
|---|---|
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab | 3 |
Response was measured by the International Workshop to Standardize Response Criteria for non-Hodgkin's Lymphoma. Complete Response (CR) is a complete disappearance of all detectable clinical and radiographic evidence of disease and disappearance of all disease-related symptoms if present before therapy, and normalization of those biochemical abnormalities (e.g., Lactate dehydrogenase (LDH) definitely assignable to the lymphoma. Complete Response Unconfirmed (CRu) is as per CR criteria except that if a residual node is > 1.5cm, it must have regressed by > 75% in the sum of the products of the greatest diameters (SPD). Partial Response (PR) is ≥50% decreased in the SPD of 6 largest dominant nodes or nodal masses. Stable Disease (SD) is defined as less than a PR but not progressive disease. Progression is ≥50% increase from nadir in the SPD of any previously involved node or the appearance of any new lesion. (NCT00005780)
Timeframe: After 6 cycles of EPOCH-R therapy, an average of 18 weeks
| Intervention | percentage of participants (Number) | ||||
|---|---|---|---|---|---|
| Complete Response | Complete Response Unconfirmed | Partial Response | Stable Disease | Progression | |
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab | 80.8 | 7.7 | 7.7 | 0 | 3.8 |
Serious and/or non-serious adverse events were assessed by the Common Toxicity Criteria (CTC v2.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life-threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. Grade 3 is severe, Grade 4 is life-threatening, and Grade 5 is death related to adverse event. (NCT00005780)
Timeframe: Up to 30 days after last intervention, up to 12.5 months or 1.04 years
| Intervention | percentage of participants (Number) | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergic reaction | Anemia | Febrile neutropenia | Leukopenia | Lymphopenia | Neutropenia | Thrombocytopenia | Thrombosis | Infusion related reaction | Serum glutamic oxaloacetic transaminase (SGOT) elevation | Serum glutamic pyruvic transaminase (SGPT) elevation | Infection | Hyperglycemia | Hypomagnesemia | Cerebrovascular ischemia | Motor neuropathy | Sensory neuropathy | Back pain | Dyspnea | Erectile dysfunction | |
| Grade 3 | 3.8 | 69.2 | 42.3 | 0 | 38.5 | 0 | 50 | 15.4 | 3.8 | 3.8 | 3.8 | 15.4 | 3.8 | 3.8 | 0 | 11.5 | 3.8 | 3.8 | 3.8 | 3.8 |
| Grade 4 | 0 | 3.8 | 3.8 | 84.6 | 0 | 88.5 | 7.7 | 0 | 0 | 0 | 0 | 3.8 | 0 | 0 | 3.8 | 0 | 0 | 0 | 0 | 0 |
| Grade 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Participants with tumor specific T-cell responses during B-cell recovery was assessed in a Clinical Laboratory Improvement Amendments (CLIA) certified lab and were measured by flow cytometry and/or enzyme-linked immunosorbent spot (ELISPOT). A positive response required the response to be at least twice the negative controls. (NCT00005780)
Timeframe: After vaccinations administered at 0, 1, 2, 3 and 5 months
| Intervention | percentage of participants (Number) | |||
|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | Granulocyte macrophage colony-stimulating factor (GM-CSF) | Tumor necrosis factor α (TNFα) | Interferon-gamma (IFN-γ) | |
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab | 87 | 65 | 52 | 74 |
15 reviews available for mechlorethamine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Lipomatosis: an unusual side-effect of cytotoxic chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Lipomatosis; Lymphoma, Non-Hodgkin; Male; Me | 2010 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine | 2003 |
What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2004 |
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined | 2005 |
Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1984 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyt | 1995 |
[Recent progress in the chemotherapy of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamid | 1995 |
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; C | 1996 |
Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Cyclo | 1995 |
[Chemotherapy for non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1998 |
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; | 1992 |
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxor | 1991 |
[The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1988 |
[Current status of chemotherapy in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1989 |
Recently recognized complications of cancer chemotherapy.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Death, Sudden; Drug Therapy, Combination; | 1974 |
21 trials available for mechlorethamine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Europe; Female; Follow-Up S | 2005 |
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; C | 1994 |
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 1994 |
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined | 1994 |
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1995 |
Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; | 1995 |
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; C | 1996 |
Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined | 1996 |
Inhibin A concentrations in the sera of young women during and after chemotherapy for lymphoma: correlation with ovarian toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1998 |
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; | 2000 |
Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.
Topics: Antineoplastic Agents; Bleomycin; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Doxorubic | 1975 |
Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; | 1977 |
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
Topics: Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration | 1977 |
Lymphosarcoma. A comparison of extended to conservative chemotherapy.
Topics: Adult; Aged; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; | 1976 |
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxor | 1991 |
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxor | 1991 |
ProMACE-MOPP vs MACOP-B in high grade non-Hodgkin's lymphomas: a randomised study in a multicenter cooperative study group (NHLCSG).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 1991 |
[Low-grade non-Hodgkin's lymphoma in the adult: new therapeutic approaches].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; | 1987 |
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1988 |
Chemotherapy of lymphoma with mechlorethamine and vinblastine.
Topics: Adult; Blood Cell Count; Blood Platelet Disorders; Clinical Trials as Topic; Evaluation Studies as T | 1973 |
Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin's disease and the lymphomas.
Topics: Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Dosage Forms; Follow-Up Studies; Hodgkin D | 1968 |
142 other studies available for mechlorethamine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Doxorubicin; Lymphoma; | 2023 |
Management of chlormethine gel treatment in mycosis fungoides patients in two German skin lymphoma centers.
Topics: Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis Fungoides; Neoplasms, Connective Tissue; Ski | 2021 |
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Combined Mod | 2014 |
Unusual changes in lymphosarcoma under nitrogen mustard therapy.
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine | 1948 |
Nitrogen mustard therapy of lymphosarcoma; report of a case.
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mustard Compounds; Mustard Plant; Neoplasms; Nitro | 1948 |
Nitrogen-mustard therapy for Hodgkin's disease, lymphosarcoma, the leukemias, and other disorders.
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mustard Plant; Nitrogen | 1948 |
Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma.
Topics: Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Sarco | 1948 |
Nitrogen mustard as a therapeutic agent for Hodgkin's disease, lymphosarcoma and leukemia.
Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine | 1947 |
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: Amines; Gas Poisoning; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechloret | 1946 |
First use of intravenous chemotherapy cancer treatment: rectifying the record.
Topics: Antineoplastic Agents; Head and Neck Neoplasms; History, 20th Century; Humans; Infusions, Intravenou | 2011 |
[Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma].
Topics: Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
[Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
Topics: Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymp | 1953 |
[Treatment of symptomatic hemolytic anemias].
Topics: Anemia, Hemolytic; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; | 1953 |
Treatment of Hodgkin's disease and the lymphosarcomas.
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compound | 1954 |
[An autopsy case of reticulosarcomatosis treated with nitrogen mustard-N-oxide].
Topics: Autopsy; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Nitroge | 1953 |
Disseminated lymphoblastoma resembling pulmonary tuberculosis; temporary dramatic response to nitrogen mustard therapy; case report.
Topics: Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Tuberculosis, | 1954 |
[Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions].
Topics: Ethylamines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1953 |
Biological actions and therapeutic applications of nitrogen mustard.
Topics: Hodgkin Disease; Leukemia; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitr | 1954 |
Treatment of the resistant stages of Hodgkin's disease and lymphoblastic diseases.
Topics: Cortisone; Hodgkin Disease; Lymphocytes; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen | 1954 |
[Therapeutic use of embichin].
Topics: Hodgkin Disease; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1954 |
[Lymphosarcoma in children].
Topics: Child; Infant; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Radioth | 1954 |
the use of nitrogen mustard in the treatment of lymphoblastomas.
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1955 |
Reticulo-sarcoma of the stomach successfully treated with nitrogen mustard.
Topics: Animals; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; | 1956 |
[The resistant stage in lymphoblastomic diseases].
Topics: Cortisone; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1955 |
Rapid and extensive development of amyloidosis in association with nitrogen mustard therapy; report of a case.
Topics: Amyloidosis; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloreth | 1956 |
[Clinical study of the antineoplastic effect of DL-p-bis(beta-chloroethyl) aminophenylalanine].
Topics: Animals; Antineoplastic Agents; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non- | 1956 |
[Clinical study of the antineoplastic effect of DL-p-bis(beta-chloroethyl) aminophenylalanine].
Topics: Animals; Antineoplastic Agents; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non- | 1956 |
[Clinical study of the antineoplastic effect of DL-p-bis(beta-chloroethyl) aminophenylalanine].
Topics: Animals; Antineoplastic Agents; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non- | 1956 |
[Clinical study of the antineoplastic effect of DL-p-bis(beta-chloroethyl) aminophenylalanine].
Topics: Animals; Antineoplastic Agents; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non- | 1956 |
[Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoid Tiss | 1956 |
[Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1957 |
[P-bis-(beta-chloroethyl) aminophenylalanine (sarcolysin) in antiblastic chemotherapy with special reference to lymphatic blood diseases].
Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloret | 1958 |
[Treatment of lymphosarcoma].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1958 |
Prophylactic treatment of the Murphy Sturm rat lymphosarcoma with nitrogen mustard.
Topics: Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1958 |
A CLINICAL study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkin's disease, lymphosarcoma, and melanoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Hodgkin Disease; Humans; Leucine; Lymphoma; Lymphoma | 1959 |
Hyperuricemia with uric acid nephropathy following nitrogen mustard therapy of lymphosarcoma; report of a case.
Topics: Hyperuricemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Uric Ac | 1959 |
A cytological evaluation of combined therapy in the 6C3HED lymphosarcoma. I. -SH-containing analogs in combination with nitrogen mustard and mapharsen.
Topics: Antineoplastic Agents; Arsenicals; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Organic | 1960 |
[A case of prolonged remission of lymphosarcomatosis after sarcolysin and roentgen-ray therapy].
Topics: Lymphoma, Non-Hodgkin; Mechlorethamine; Melphalan; Nitrogen Mustard Compounds | 1960 |
The action of nitrogen mustards on the glycolysis and hexokinase activity of rat reticulo-sarcoma ascites cells.
Topics: Animals; Ascites; Carbohydrate Metabolism; Carbohydrates; Glycolysis; Hexokinase; Lymphoma, Large B- | 1961 |
A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin's disease and lymphosarcoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Cyclophosphamide; Hodgkin Disease; Lung Neoplasms; L | 1962 |
Topical nitrogen mustard in cutaneous lymphosarcoma (mycosis fungoides).
Topics: Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Musculoskeletal Diseases; Mycosis Fungoides; Skin Ne | 1962 |
THE MALIGNANT LYMPHOMAS.
Topics: Adrenal Cortex Hormones; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma | 1963 |
[TEST OF THE ACTION OF SOME NITROGEN MUSTARD DERIVATIVES ON STICKER'S LYMPHOSARCOMA].
Topics: Animals; Cyclophosphamide; Dogs; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Neopla | 1963 |
RADIATION PNEUMONITIS. CASE REPORT OF BILATERAL REACTION AFTER UNILATERNAL IRRADIATION.
Topics: Child; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mediastinal Neoplasms | 1964 |
EXCRETION OF TRYPTOPHAN METABOLITES IN DIFFERENT FORMS OF HAEMOBLASTOSIS.
Topics: Cortisone; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Kynurenic Acid; Ky | 1964 |
COMPRESSION OF THE SPINAL CORD IN PATIENTS WITH MALIGNANT LYMPHOMA.
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloret | 1964 |
COMPARISON OF EFFECTS OF CHEMOTHERAPY AND LOCAL IRRADIATION ON THE VASCULARITY OF A TRANSPLANTED MOUSE LYMPHOSARCOMA; A STUDY USING ANGIOGRAPHY AND MICROANGIOGRAPHY.
Topics: Angiography; Animals; Blood Vessels; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mice; Neoplas | 1964 |
WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS.
Topics: Anemia; Anemia, Hemolytic; Betamethasone; Chlorambucil; Dexamethasone; Geriatrics; Humans; Leukemia; | 1964 |
PHAGOCYTOSIS IN RETICULUM CELL SARCOMA.
Topics: Adolescent; Black People; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Geriatrics; Leukemia; | 1964 |
PRIMARY RETICULUM CELL SARCOMA OF THE LUNG WITH ENDOBRONCHIAL INVOLVEMENT. CASE REPORT.
Topics: Biopsy; Bronchial Neoplasms; Bronchoscopy; Cytodiagnosis; Humans; Lung Neoplasms; Lymphoma, Large B- | 1964 |
[HISTOPATHOLOGICAL EFFECTS OF ANTINEOPLASTIC AGENTS ON MALIGNANT LYMPHOMA].
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Geriatrics; Hodgkin Dise | 1964 |
STUDIES ON REGIONAL PERFUSION AND INTRA-ARTERIAL INFUSION FOR CANCER CHEMOTHERAPY.
Topics: Antineoplastic Agents; Breast Neoplasms; Celiac Artery; Chemotherapy, Cancer, Regional Perfusion; Co | 1964 |
LONG TERM RESULTS ACHIEVED WITH THE USE OF ALKYLATING AGENTS IN MALIGNANT LYMPHOMA AND HODGKIN'S DISEASE.
Topics: Alkylating Agents; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg | 1964 |
LYMPHANGIOGRAPHY FOR MALIGNANT DISEASES IN CHILDREN.
Topics: Adolescent; Child; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Myeloid; Lymph Nodes; Lympha | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen | 1964 |
THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
Topics: Adrenal Cortex Hormones; Busulfan; Chlorambucil; Cortisone; Cyclophosphamide; Hodgkin Disease; Human | 1964 |
RELATIONSHIP BETWEEN CELL TYPE, GLUCOSE CONCENTRATION, AND RESPONSE TO TREATMENT IN NEOPLASTIC EFFUSIONS.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adolescent; Alkylating Agents; Antimetabolites; Antineoplastic | 1964 |
LYMPHOSARCOMA OF THE ILEUM. A CASE REPORT AND DISCUSSION.
Topics: Ascites; Ileum; Intestinal Neoplasms; Lymph Nodes; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasm | 1964 |
LYMPHOSARCOMA PRODUCING MIKULICZ SYNDROME.
Topics: Drug Therapy; Geriatrics; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mikulicz' Diseas | 1964 |
LONG-TERM RESULTS OF X-RAY TREATMENT IN MALIGNANT DISEASE OF THE LYMPHO-RETICULAR SYSTEM.
Topics: Classification; England; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodg | 1964 |
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leu | 1965 |
INTENSIVE NITROGEN MUSTARD THERAPY WITH ABDOMINAL AORTIC OCCLUSION IN NASOPHARYNGEAL CARCINOMA.
Topics: Adenocarcinoma; Antineoplastic Agents; Aorta; Aorta, Abdominal; Busulfan; Carcinoma; Carcinoma, Squa | 1965 |
[Results of prolonged treatment with chloronaphthyne in a case of reticulum cell sarcoma; preliminary note].
Topics: Abdomen; Abdominal Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamin | 1955 |
Effect of chlorambucil on synthesis of protein and nucleic acids in tumor-bearing mice.
Topics: Animals; Chlorambucil; Lymphoma, Non-Hodgkin; Mechlorethamine; Mice; Neoplasms; Nitrogen Mustard Com | 1960 |
[The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1959 |
[Results obtained with the use of chlorambucil in the treatment of malignant lymphopathies].
Topics: Chlorambucil; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodg | 1961 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2003 |
Nitrogen mustards in the treatment of neoplastic disease.
Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis | 1950 |
[Blood proteins and lymphosarcoma].
Topics: Blood Proteins; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarco | 1950 |
The partition of radio-phosphorus (P32) in blood, urine and tumor tissue in patients with Hodgkin's disease and lymphosarcoma before and after treatment with nitrogen mustard [methyl bis (beta-chloroethyl) amine].
Topics: Amines; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Phosph | 1950 |
Treatment of lymphosarcoma with nitrogen mustard.
Topics: Animals; Dogs; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Nitrogen Mustard Compoun | 1951 |
[Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].
Topics: Amines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplas | 1951 |
[Ileo-mesenteric lymphosarcomata; trial treatment with nitrogen mustard].
Topics: Ileum; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mesentery; Neoplasms; Nitrogen Mustard Comp | 1951 |
[Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compou | 1951 |
[Naphthyl-chloroethylamine therapy of Hodgkin's disease and allied forms].
Topics: Cystitis; Hodgkin Disease; Lymphogranuloma Venereum; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplas | 1950 |
The principles of radiation therapy of lymphoblastoma.
Topics: Hodgkin Disease; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Sarco | 1951 |
[On nitrogen mustard therapy of mycosis fungoides. II. Histologic studies].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis Fungoides; Nitrogen Mustard Compounds | 1951 |
[Case of mycosis fungoides treated with nitrogen mustard].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis Fungoides; Nitrogen Mustard Compounds | 1951 |
Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1951 |
[Case of mycosis fungoides].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis Fungoides; Nitrogen Mustard Compounds | 1951 |
Therapeutic options in patients with lymphoma and severe liver dysfunction.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antibodies, Monoclona | 2004 |
[A case of lymphosarcoma treated with nitrogen mustard].
Topics: Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma | 1949 |
Lymphosarcoma treated with nitrogen mustard; report of a case.
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma | 1950 |
[Treatment of a lymphosarcoma of the neck by combination of nitrogen mustard, radiotherapy and surgery].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neck; Neoplasms; Nitrogen Mustard Compounds; Radio | 1950 |
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2006 |
Topical mechlorethamine and clobetasol in multifocal primary cutaneous marginal zone-B cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clobetasol; Humans; Lymphoma, B-Cell; Lymphom | 2006 |
Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.
Topics: Amines; Ethylamines; Hodgkin Disease; Humans; Leukemia; Lung Diseases; Lung Neoplasms; Lymphoma; Lym | 1949 |
The use of nitrogen mustard in Hodgkin's disease and lymphosarcoma.
Topics: Ethylamines; Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Sarcoma | 1949 |
Action of elatericin A on human leukemic and normal lymphocytes.
Topics: Aminopterin; Animals; Antineoplastic Agents; Azirines; Cathartics; Cell Nucleus; Chlorambucil; Cyclo | 1967 |
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
Combination chemotherapy ("MABOP") in advanced refractory lymphocytic lymphoma with unfavorable histology.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxor | 1982 |
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: History, 20th Century; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Ne | 1984 |
Composite lymphoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma | 1984 |
Deferral of initial therapy for advanced indolent lymphomas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therap | 1982 |
Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dexametha | 1993 |
Myelodysplastic syndrome after autologous transplant for lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Hodgkin Dis | 1994 |
Excretion of Ascaris lumbricoides during total body irradiation.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascariasis; Ascaris lumbricoides; Bo | 1994 |
Relapsing chickenpox in a young man with non-Hodgkin's lymphoma.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Cyclophosphamide; Doxo | 1994 |
2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.
Topics: Cladribine; Cytarabine; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leuk | 1993 |
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1994 |
[Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymphoma, No | 1995 |
[Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Ch | 1997 |
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, P | 1996 |
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubi | 1996 |
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherap | 1997 |
Ex vivo pharmacological purging of leukapheresis collections with nitrogen mustard: amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery.
Topics: Amifostine; Animals; Bone Marrow Purging; Cell Survival; Cells, Cultured; Colony-Forming Units Assay | 1999 |
Adult head and neck lymphomas in Papua New Guinea: a retrospective study of 70 cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modali | 1999 |
Follow-up of sperm concentration and motility in patients with lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Daca | 2000 |
Interferon does not prolong progression-free survival after ProMACE-MOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamid | 2000 |
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 2001 |
Palliation in malignant pleural effusion.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Drainage; Female; Hodgkin Disease; Humans; Lung Neopl | 1975 |
Histiocytic lymphoma of B cell origin.
Topics: B-Lymphocytes; Cell Membrane; Humans; Immunoglobulins; Lymphoma, Large B-Cell, Diffuse; Lymphoma, No | 1977 |
[Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphom | 1976 |
Malignant lymphoma presenting as unilateral exophtalmos and thyroid nodule (author's transl)
Topics: Axilla; Exophthalmos; Heart Neoplasms; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamin | 1975 |
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymph Nodes | 1975 |
Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 1992 |
Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cells, Cultured; Chromosome Aberrations | 1992 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 1991 |
Failure of conventional chemotherapy in aggressive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1987 |
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1988 |
Non-Hodgkin's lymphoma in the elderly: a retrospective evaluation of toxicity related to aggressive vs. conservative treatments.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1988 |
The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Damage; Doxorubicin; Hodgkin D | 1988 |
[Second tumors in patients treated for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modali | 1988 |
The treatment of malignant pleural effusions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamou | 1974 |
In vitro estimate of sensitivity of individual human tumors to antitumor agents.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenicals; Benzoates; Breast Neoplasms; Carbon Radi | 1974 |
Temporary resolution of geographic tongue with cytotoxic therapy.
Topics: Child; Drug Therapy, Combination; Glossitis, Benign Migratory; Humans; Lymphoma, Non-Hodgkin; Male; | 1974 |
[False facial cellulitis: hematosarcoma].
Topics: Cellulitis; Diagnosis, Differential; Drug Therapy, Combination; Facial Neoplasms; Humans; Hydrazines | 1973 |
Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man.
Topics: Adult; Biopsy; Cell Count; Clomiphene; Cyclophosphamide; Follicle Stimulating Hormone; Hodgkin Disea | 1972 |
Reticulum cell sarcoma. A review of radiotherapeutic experience.
Topics: Adolescent; Adult; Aged; Chlorambucil; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mal | 1972 |
[Chylous effusion during reticulosarcoma].
Topics: Abdominal Neoplasms; Chylothorax; Humans; Hydrazines; Inguinal Canal; Lumbosacral Region; Lymphatic | 1973 |
The place of chemotherapy in Hodgkin's disease and allied disorders.
Topics: Blood Cell Count; Hodgkin Disease; Humans; Laparotomy; Liver Function Tests; Lymphoma, Large B-Cell, | 1972 |
Management of patients with non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Lymphography; Ly | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-C | 1973 |
Status and perspectives in chemotherapy of Hodgkin's disease.
Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cyt | 1973 |
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma.
Topics: Adult; Aged; Antineoplastic Agents; Benzoates; Bone Marrow; Female; Follow-Up Studies; Humans; Leuko | 1970 |
Combined chemotherapy and radiotherapy for advanced Hodgkin's disease and reticulum cell sarcoma: a preliminary report.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lympho | 1971 |
Mucha-Habermann disease mistaken for reticulum cell sarcoma.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Diagnosis, Differential; Female; Humans; Hypothyroidism; Lympho | 1971 |
[Prolonged remission of reticulum cell sarcoma].
Topics: Cyclophosphamide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Ag | 1971 |
Combination chemotherapy in malignant disease.
Topics: Administration, Oral; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; Child, Preschool; Fem | 1971 |
Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents.
Topics: Agranulocytosis; Alkylating Agents; Bone Marrow Cells; Bone Marrow Examination; Cyclophosphamide; En | 1972 |
The management of pleural effusions and chylothorax in lymphoma.
Topics: Adult; Chylothorax; Exudates and Transudates; Female; Humans; Leukemia, Lymphoid; Lymphoma, Large B- | 1965 |
Recent advances in chemotherapy of lymphoma.
Topics: Alkylating Agents; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg | 1967 |
Preoperative irradiation and chemotherapy in the prevention of surgical failures: experimental observations on an animal tumor model.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Lymphoma, Non-Hodgkin; Mechlorethamine; Mice; Mode | 1969 |
X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Chlorambucil; Humans; Leukemia, Lymphoid; Lymphoma, Non- | 1966 |